Notes - Statement Of Income

STELLA PHARMA CORPORATION - Filing #7320249

Concept 2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
Notes - Statement of income
Notes - Statement of income
Notes regarding amount of revenue from contracts with customers

※1 顧客との契約から生じる収益

売上高については、顧客との契約から生じる収益を記載しております。

Notes regarding write-downs of inventories
Write-downs of inventories
19,502,000 JPY
-4,000,000 JPY
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
393,555,000 JPY
374,345,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.